Similar articles

• Dipropylacetate (valproate) and glycine metabolism.

  Jaeken J, Corbeel L, Casaer P, Carchon H, Eggermont E, Eeckels R. Jaeken J, et al. Lancet. 1977 Sep 17;2(8038):617. doi: 10.1016/s0140-6736(77)91475-1. Lancet. 1977. PMID: 71442 No abstract available.
• Valproate, hyperammonaemia, and hyperglycinaemia.

  Jaeken J, Casaer P, Corbeel L. Jaeken J, et al. Lancet. 1980 Aug 2;2(8188):260. doi: 10.1016/s0140-6736(80)90148-8. Lancet. 1980. PMID: 6105420 No abstract available.
• Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate.

  Lecchini S, Gatti G, De Bernardi M, Caravaggi M, Frigo GM, Calzetti S, Visintini D. Lecchini S, et al. Farmaco Prat. 1978 Feb;33(2):80-2. Farmaco Prat. 1978. PMID: 344060 No abstract available.
• Valproate may lower serum-phenytoin.

  Bardy A, Hari R, Lehtovaara R, Majuri H. Bardy A, et al. Lancet. 1977 Jun 11;1(8024):1256-7. doi: 10.1016/s0140-6736(77)92460-6. Lancet. 1977. PMID: 68349 No abstract available.
• Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

  Pinder RM, Brogden RN, Speight TM, Avery GS. Pinder RM, et al. Drugs. 1977 Feb;13(2):81-123. doi: 10.2165/00003495-197713020-00001. Drugs. 1977. PMID: 402258 Review.